KLOW is a synergistic peptide blend combining four research-backed compounds: KPV, BPC-157, TB-500, and GHK-Cu. Janoshik Analytical tested the current lot: (report 77797)
Measured2 vials
Figures copied exactly from Janoshik Analytical's report #77797.
Catalog no. PH-KLOW-001Size 80mgMW (reference) See documentationSequence Proprietary blend formulation
KLOW is a synergistic peptide blend combining four research-backed compounds: KPV, BPC-157, TB-500, and GHK-Cu. This multi-peptide formula targets connective-tissue signaling, inflammatory signaling pathways, and extracellular matrix biology.
Components & Mechanisms
KPV - A tripeptide derived from α-MSH that inhibits NF-κB activation and reduces pro-inflammatory cytokines. PepT1-mediated KPV uptake reduces intestinal inflammation at nanomolar concentrations (Dalmasso et al., 2008).
BPC-157 - Stable gastric pentadecapeptide that promotes wound healing and angiogenesis. BPC 157 accelerates healing of various tissue wounds including skin, muscle, tendon, and bone (Sikiric et al., 2021).
TB-500 (Thymosin Beta-4) - A multi-functional regenerative peptide that promotes cell migration, angiogenesis, and connective-tissue signaling. Thymosin β4 plays a vital role in the repair and regeneration of injured cells and tissues (Goldstein et al., 2012).
GHK-Cu - A copper-binding tripeptide that modulates multiple cellular pathways in skin regeneration, stimulating collagen synthesis and wound healing (Pickart et al., 2015).
Research Applications
Product Specifications
References
KLOW is supplied as a lyophilized powder. Keep it sealed, dry, and away from light until reconstitution.
Lyophilized material is stable when frozen. Once reconstituted, keep it cold and minimise handling to preserve integrity.
KLOW is a synthetic peptide compound used in laboratory research settings. Researchers studying metabolic regulation and energy homeostasis use this compound to investigate cellular signaling pathways, receptor binding affinities, and structure-activity relationships. Its available Certificate of Analysis documents the reported laboratory results.
KLOW is a research compound supplied for in-vitro laboratory use. Sequence: Proprietary blend formulation. Supplied for metabolic research laboratory research. A third-party Certificate of Analysis is published for the current lot. Research Use Only — not for human or veterinary use.
The current Janoshik Analytical report for KLOW (77797) measures content per vial; it does not print an HPLC purity figure.
Yes. Janoshik Analytical report 77797 for KLOW is on our COA page, with a link to the lab's own report.
KLOW is supplied as a lyophilized powder. Store it at −20°C or below, protected from light and moisture — lyophilized material is stable frozen. Once reconstituted, keep it refrigerated and avoid freeze-thaw cycles.
Orders ship at a $15 flat rate, free on orders of $200 or more, in discreet, insulated packaging. Domestic delivery takes 2–3 business days — 2-day across California, nearby Nevada, and on orders of $250+.
No. KLOW is supplied strictly for in-vitro laboratory research. It is not for human or veterinary use, consumption, or diagnostic or clinical applications.
Open the lab report link on our certificate page — it goes to Janoshik Analytical's own verification portal, not a file we host, so the result can't be edited by us. Confirm the report ID (77797) and figures match what's shown here.
The 80mg size of KLOW is $2.00 per mg. See the size selector above for per-mg pricing on every available size.
